Solute carrier family 25 member 19 (SLC25A19) is a transporter protein of thiamine pyrophosphate across cellular membranes, which is needed as a cofactor for multiple metabolic enzymes and is ...

have been accepted for presentation at the American Association for Cancer Research (AACR) Annual Meeting 2025, on April 25 - 30 in Chicago. Tempus researchers will showcase scientific and ...

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide. Circulating cell-free DNA (cfDNA) methylation markers offer a promising approach for early cancer ...

The FDA has granted full approval to Bristol Myers Squibb’s (BMS) dual immunotherapy regimen of Opdivo (nivolumab) plus Yervoy (ipilimumab) for adults with unresectable or metastatic hepatocellular ...

Children accounted for 4.2% of the scans. The researchers excluded tests in the patient's last year of life because it was unlikely to lead to cancer. Adults 50 to 59 had the highest number of ...

Abstract: Early screening to improve the survival rate of hepatocellular carcinoma (HCC) patients remains a critical clinical challenge. However, current methods for early cancer detection still lack ...

Linda Kelly, 67, has advanced breast cancer which has spread to her bones and chest wall, but says a new pill has given her extra years of life and time to travel with her husband. "It does let ...

The FDA approved nivolumab and ipilimumab for unresectable or metastatic hepatocellular carcinoma, a prevalent and deadly liver cancer in the U.S. CHECKMATE-9DW trial results showed improved ...